Evemus 0.25 mg

Evemus 0.25 mg

उत्पादन तपशील:

  • शारीरिक फॉर्म गोळ्या
  • साठी शिफारस केली Medical Treatment
  • डोस 0.25 mg
  • डोस मार्गदर्शक तत्त्वे As directed by the physician
  • स्टोरेज सूचना Keep In a Cool & Dry Place
  • Click to view more
X

एवेमस 0.25 मिग्रॅ किंमत आणि प्रमाण

  • बॉक्स/बॉक्स
  • बॉक्स/बॉक्स
  • 500

एवेमस 0.25 मिग्रॅ उत्पादन तपशील

  • 0.25 mg
  • Medical Treatment
  • As directed by the physician
  • गोळ्या
  • Keep In a Cool & Dry Place

एवेमस 0.25 मिग्रॅ व्यापार माहिती

  • दिवस
  • आशिया ऑस्ट्रेलि मध्य अमेरिका पूर्व युरोप साउथ अमेरिका उत्तर अमेरिका पश्चिम युरोप मध्य पूर्व आफ्रिका
  • संपूर्ण भारत

उत्पादन तपशील

Everolimus tablets (Evemus 0.25 mg) is a medication used in the treatment of various cancers and certain other conditions. It belongs to a class of drugs known as mTOR inhibitors, which work by inhibiting the mammalian target of rapamycin (mTOR) protein in cells, thereby slowing down the growth of cancer cells.

Everolimus is available in tablet form for oral administration. The dosage and administration schedule may vary depending on the specific condition being treated, the patients medical history, and other factors. Its important to take Everolimus exactly as prescribed by a healthcare professional.

Common side effects of Everolimus may include mouth sores, diarrhea, nausea, vomiting, loss of appetite, weakness, rash, and swelling of the hands/feet/ankles. Serious side effects are also possible, so its essential to report any unusual symptoms or side effects to a doctor promptly.

As with any medication, its important to discuss potential benefits and risks with a healthcare provider before starting treatment with Everolimus. They can provide personalized guidance based on individual health circumstances.
खरेदी आवश्यकता तपशील प्रविष्ट करा
ई - मेल आयडी
मोबाईल क्र.

Pharmaceutical Tablets मध्ये इतर उत्पादने



“हम केवल बल्क ऑर्डर मात्रा को स्वीकार कर रहे हैं। “।